Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DiGluClα3B is a subunit of the glutamate-gated chloride channel (GluCl) found in the parasitic nematode Dirofilaria immitis, which causes heartworm disease in dogs and cats [4, 14]. It belongs to the Cys-loop ligand-gated ion channel superfamily and is a splice variant of the avr-14 gene [18, 20]. This receptor is a primary molecular target for macrocyclic lactones, such as ivermectin and moxidectin, which are widely used as heartworm preventatives [4, 5]. When these drugs bind to the DiGluClα3B subunit, they act as potent agonists, causing the channel to open and allow an influx of chloride ions [18, 22]. This leads to hyperpolarization of the parasite's neurons and muscles, resulting in flaccid paralysis and eventual death or expulsion of the worm [5, 18]. Because GluCls are absent in vertebrates, these drugs exhibit high selective toxicity toward the parasite [15, 17]. However, the emergence of macrocyclic lactone resistance in D. immitis populations has made the study of DiGluClα3B and its polymorphisms a critical area of veterinary research [4, 17]. Understanding the pharmacological properties and expression patterns of this subunit is essential for developing next-generation anthelmintics to combat resistant heartworm strains [1, 19].
Agonist of the glutamate-gated chloride channel, leading to hyperpolarization and paralysis of the parasite [4, 18].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dirofilaria immitis glutamate-gated chloride channel alpha 3B subunit (DiGluClα3B) (DiGluClα3B).